Poland· PL-100300880

Mybracin

A dexamethason und antiinfektiva product containing tobramycinum + dexamethasonum, registered in Poland by Adamed Pharma S.A.. The same ATC class is registered in 6 of our 19 countries.

ATC S02CA06

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedMybracinATCS02CA06REGISTER NO.PL-100300880PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Dexamethason und antiinfektiva is registered in 6 of 19 countries.

Countries holding a registration under ATC S02CA06 (dexamethason und antiinfektiva), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Dexamethason und antiinfektiva · ATC S02CA06

6 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Tobramycinum + Dexamethasonum
Manufacturer
Adamed Pharma S.A.
Country
Poland (PL)
ATC code
S02CA06
ATC class
Dexamethason und Antiinfektiva
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991073084

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dexamethason und antiinfektiva in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexamethason und antiinfektiva products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Tobradex
  • Belgium · Tobradex
  • Bulgaria · Декс-Тобрин, Медетром
  • Cyprus · Lofoto, Tobradex
  • Czechia · Tobradex
  • Germany · Tobradex
  • Denmark · Oridecin, Tobradex
  • Estonia · Tobradex, Tobramycin/Dexamethasone Elvim
  • Spain · Tobradex
  • Finland · Tobrasone
  • France · Tobradex, Todexal
  • United Kingdom (Northern Ireland) · Tobradex, Tobramycin + Dexamethasone Blumont Pharma
  • Greece · Lofoto, O-Biotic
  • Croatia · Tobradex
  • Hungary · Tobradex, Todep
  • Iceland · Tobradex
  • Italy · Iridina Infezioni E Infiammazioni, Luxabiotic
  • Lithuania · Tobradex, Tobramycin/Dexamethasone Elvim
  • Luxembourg · Tobradex
  • Latvia · Tobradex, Tobramycin/Dexamethasone Elvim
  • Malta · Tobradex
  • Netherlands · Bradexa, Tobradex
  • Norway · Tobrasone, Toflacort
  • Portugal · Dextob, Tobradex
  • Romania · Dexatobrom, Tobradex
  • Sweden · Tobrasone, Toflacort
  • Slovenia · Tobradex
  • Slovakia · Tobradex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1aead2aa-0fcd-430a-8d0b-1ce34cea5ccc
GET /v1/drugs/1aead2aa-0fcd-430a-8d0b-1ce34cea5ccc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople do oczu, zawiesina",
  "source": "urpl",
  "strength": "(3 mg + 1 mg)/ml",
  "packaging": "05909991073084 ¦ Rp ¦ 85364\n1 butelka 5 ml",
  "substance": "Tobramycinum 3 mg/ml + Dexamethasonum 1 mg/ml",
  "common_name": "Tobramycinum + Dexamethasonum",
  "pl_product_id": "100300880",
  "pozwolenie_nr": "21342",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about dexamethason und antiinfektiva.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.